MELODY PERLBERG: Open Payments
NPI 1891045985 · MINEOLA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,252 in 122 payments from 18 companies in 2025. Trend: 2023 $3,534 · 2024 $2,547 · 2025 $2,252
Food & beverage: $2,252
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 11 | $337 |
| Axsome Therapeutics, Inc. | 15 | $311 |
| ABBVIE INC. | 14 | $235 |
| Otsuka America Pharmaceutical, Inc. | 13 | $223 |
| Tris Pharma Inc | 20 | $208 |
| Vanda Pharmaceuticals Inc. | 10 | $171 |
| E.R. Squibb & Sons, L.L.C. | 8 | $148 |
| Corium, LLC | 6 | $122 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $89 |
Products named: UZEDY, Auvelity, REXULTI, VRAYLAR, Dyanavel XR, FANAPT, COBENFY, Azstarys.
Industry payments across NY — which companies pay providers there.
